Back
Roche Holding AG Vs. Novo Nordisk AS Industry Stock Comparison
Sell
36
RHHBY
Roche Holding AG
Last Price:
38.81
Seasonality Move:
4.12%
Sell
39
NVO
Novo Nordisk AS
Last Price:
111.96
Seasonality Move:
7.41%
Sell
36
Roche Holding AG (RHHBY)
is a Sell
Is Roche Holding AG a Buy, Sell or Hold?
- The current Roche Holding AG [RHHBY] share price is $39.46. The Score for RHHBY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- RHHBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $113.24. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHHBY Stock Price Chart
What is Roche Holding AG's stock price today?
-
The Roche Holding AG share price today is $39.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHHBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $113.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
RHHBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 48.88 | Sell |
| Chaikin Money Flow: | 484607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.58 - 40.12) | Buy |
| Bollinger Bands (100): | (36.07 - 41.01) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.33 | Sell |
| Relative Strength Index (14 RSI): | 33.23 | Sell |
| Chaikin Money Flow: | 9284762 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.98 - 120.7) | Sell |
| Bollinger Bands (100): | (121.55 - 140.81) | Sell |
RHHBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.93 | Sell |
| 20-day SMA: | 39.22 | Buy |
| 50-day SMA: | 39.87 | Sell |
| 200-day SMA: | 35.41 | Buy |
| 8-day EMA: | 39.83 | Sell |
| 20-day EMA: | 39.6 | Sell |
| 50-day EMA: | 39.35 | Buy |
| 200-day EMA: | 36.99 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 114.3 | Sell |
| 20-day SMA: | 116.22 | Sell |
| 50-day SMA: | 125.51 | Sell |
| 200-day SMA: | 128.16 | Sell |
| 8-day EMA: | 114.13 | Sell |
| 20-day EMA: | 117.02 | Sell |
| 50-day EMA: | 122.76 | Sell |
| 200-day EMA: | 123.17 | Sell |
Roche Holding AG Earnings Growth & RHHBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.29 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.79 per share.
Roche Holding AG Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||